Gilead Reports Positive Late-Stage Study Results for Remdesivir in Patients With Moderate COVkpo.dID-19o and  uujk  @themotleyfool #stocks $GILD https://t.co/rOr2y9sEAm trrmmrmrrrr   ditive-late-stage-study-results-f.aspxunnonjdib ghvjf